Lipocine Inc. (LPCN)
NASDAQ: LPCN · Real-Time Price · USD
8.66
-0.01 (-0.12%)
At close: Feb 13, 2026, 4:00 PM EST
8.49
-0.17 (-1.96%)
After-hours: Feb 13, 2026, 4:10 PM EST
Lipocine Market Cap
Lipocine has a market cap or net worth of $48.08 million as of February 13, 2026. Its market cap has increased by 101.17% in one year.
Market Cap
48.08M
Enterprise Value
33.11M
1-Year Change
101.17%
Ranking
Category
Stock Price
$8.66
Market Cap Chart
Since March 21, 2014, Lipocine's market cap has decreased from $82.30M to $48.08M, a decrease of -41.58%. That is a compound annual growth rate of -4.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 48.10M | 7.85% |
| Dec 31, 2025 | 44.60M | 70.88% |
| Dec 31, 2024 | 26.10M | 76.35% |
| Dec 29, 2023 | 14.80M | -57.95% |
| Dec 30, 2022 | 35.20M | -59.77% |
| Dec 31, 2021 | 87.50M | -2.02% |
| Dec 31, 2020 | 89.30M | 811.22% |
| Dec 31, 2019 | 9.80M | -64.87% |
| Dec 31, 2018 | 27.90M | -61.73% |
| Dec 29, 2017 | 72.90M | 8.48% |
| Dec 30, 2016 | 67.20M | -71.53% |
| Dec 31, 2015 | 236.00M | 250.67% |
| Dec 31, 2014 | 67.30M | -18.23% |
| Mar 21, 2014 | 82.30M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NeurAxis | 52.31M |
| BeyondSpring | 52.23M |
| MiNK Therapeutics | 51.82M |
| Acrivon Therapeutics | 51.43M |
| Nutriband | 49.96M |
| Plus Therapeutics | 48.68M |
| Q32 Bio | 47.99M |
| Impact BioMedical | 46.62M |